Soractelite
  • Home
  • Benign Prostatic Hyperplasia
  • SoracteLite
    • Non surgical treatment
    • Testimonials
    • FAQ
  • News
  • Company
  • Contact Us
  • English
    • Italian
Select Page

EchoLaser and TPLA technique: successful procedures and international guests in Verona

Jul 29, 2025

On July 25th, 2025, at the Verona University Hospital (AOUI Verona), Professor Alessandro Antonelli and his team successfully performed three treatments for benign prostatic hyperplasia (BPH) and one focal therapy for prostate cancer using the EchoLaser system with...

EchoLaser TPLA at the 12th National Academic Conference on Minimally Invasive Surgery in Aerospace (China)

Jul 23, 2025

Over 400 experts from 28 provinces attended the 12th National Academic Conference on Minimally Invasive Surgery in Aerospace. We are proud that, for the third consecutive year, our Chinese partner, Chenglai Pharmaceutical, was among the key players at this prestigious...

Search

Archive

  • July 2025
  • September 2024
  • April 2024
  • March 2024
  • February 2024
  • December 2023
  • November 2023
  • April 2023
  • March 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • June 2022
  • May 2022
  • March 2022
  • February 2022
  • January 2022
  • November 2021
  • August 2021
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • March 2020
  • January 2020
  • December 2019
  • November 2019
  • August 2019
  • March 2019
  • October 2018
  • September 2018
  • May 2018
  • April 2018
  • November 2017
  • September 2017
  • July 2017
  • May 2017
  • Legal Notes
  • Privacy and Cookies Policy
  • Information for Customers and Suppliers

REGULATORY NOTICE USA

EchoLaser X4 is FDA cleared (510K) for tissue ablation in urology. Indications for use are however not disease specific. Although there’s solid clinical evidence, generated by a multitude of published clinical trials, confirming safety and efficacy of the treatment, patients must always discuss treatment options with a specialist doctor. It will ultimately be the specialist doctor who will determine if a patient is eligible for EchoLaser treatment.

© 2018 SoracteLite is a registered trademark in European Union by: Elesta SpA – tel.+39 055 88 26 807 – fax.+39 055 7766698
info@elesta-echolaser.com

The information published in this website is of general nature and only have an informative purpose. Under no circumstances can they replace any treatment or therapy prescribed by a physician or other healthcare professionals authorised by law. Any information on medical procedures and treatment descriptions in this website are intended for informative purposes only and do not provide the knowledge required for their application. All the indications provided at www.soractelite.info must always be backed up by the opinion of your doctor.

This site uses cookies to provide you with a better browsing experience. By accepting this banner, scrolling down this page, clicking on a link or continuing to browse in any other way, you consent to the use of cookies. If want to know more read our cookie policy.